Start the conversation
Merger Mania: According to reports, private pharmaceutical giant Actavis Plc. will announce a cash-and-stock mega-deal to buy Allergan Inc. (NYSE: AGN). The $65.5 billion deal – or $210 per share – would end months of speculation about a possible hostile takeover led by activist investor Bill Ackman. The high-profile investor had been working with Valeant Pharmaceuticals International Inc. (NYSE: VRX) to court the Botox manufacturer.